177 related articles for article (PubMed ID: 37842231)
1. Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7.
Apollonova V; Plevako D; Garanin A; Sidina E; Zabegina L; Knyazeva M; Smirnova V; Artemyeva A; Krivorotko P; Malek A
Cancer Drug Resist; 2023; 6(3):596-610. PubMed ID: 37842231
[No Abstract] [Full Text] [Related]
2. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
3. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
[TBL] [Abstract][Full Text] [Related]
4. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
Guan X; Guan Y
Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis.
Liu C; Jiang F; Zhang X; Xu X
Cancer Manag Res; 2020; 12():2777-2788. PubMed ID: 32425595
[TBL] [Abstract][Full Text] [Related]
6. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
7. MiR-26a-5p Heightens Breast Cancer Cell Sensitivity to Paclitaxel via Targeting Flap Endonuclease 1.
Cai Y; Zhang T; Chen G; Liu C
Ann Clin Lab Sci; 2023 Jan; 53(1):116-125. PubMed ID: 36889769
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
[TBL] [Abstract][Full Text] [Related]
9. Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286.
Ni J; Xi X; Xiao S; Xiao X
Cancer Manag Res; 2021; 13():5573-5585. PubMed ID: 34285578
[TBL] [Abstract][Full Text] [Related]
10. Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy.
Fan J; Tang Y; Wang K; Yang S; Ma B
Breast Cancer (Dove Med Press); 2023; 15():591-604. PubMed ID: 37593370
[TBL] [Abstract][Full Text] [Related]
11. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
[TBL] [Abstract][Full Text] [Related]
12. MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer.
Sha LY; Zhang Y; Wang W; Sui X; Liu SK; Wang T; Zhang H
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2201-8. PubMed ID: 27338043
[TBL] [Abstract][Full Text] [Related]
13. MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.
Chen L; Cao H; Feng Y
World J Urol; 2018 Mar; 36(3):357-365. PubMed ID: 29204706
[TBL] [Abstract][Full Text] [Related]
14. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
Kong Z; Han Q; Zhu B; Wan L; Feng E
Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.
Xue J; Chi Y; Chen Y; Huang S; Ye X; Niu J; Wang W; Pfeffer LM; Shao ZM; Wu ZH; Wu J
Oncogene; 2016 Jan; 35(4):448-58. PubMed ID: 25867061
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
[TBL] [Abstract][Full Text] [Related]
18. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
20. Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88.
Xiang F; Fan Y; Ni Z; Liu Q; Zhu Z; Chen Z; Hao W; Yue H; Wu R; Kang X
Front Oncol; 2019; 9():501. PubMed ID: 31259152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
